$XENE news
The latest XENE stock news: headlines, filings, AI summaries and sentiment for $XENE, updated around the clock.
- Xenon Pharmaceuticals Reports Q3 2026 Financial Results and Azetukalner FDA Submission
- Xenon Pharmaceuticals Advances Azetukalner Regulatory Path and Announces X-FIRST Study Timeline
- Xenon Pharmaceuticals Reports Q3 GAAP EPS of -$1.11, Exceeding Estimates
- Xenon Pharmaceuticals Inc. - 10-Q Filing
- Xenon Pharmaceuticals Inc. - 8-K Filing
- Xenon Pharmaceuticals Stock Drops After Halting Enrollment in Depression Trials
- Xenon Pharmaceuticals Pauses Drug Trial, Sending Shares Down
- Xenon Pharmaceuticals Downgraded by Deutsche Bank After Pausing Depression Trial Enrollment
- Stocks Making Significant Moves Midday: Netflix, Xenon Pharmaceuticals, Coinbase, Sandisk, SpaceX Among Others
- Xenon Pharmaceuticals Halts Enrollment in Clinical Trials for Azetukalner Due to Side Effects
- Stock Market Pre-Market Movers: Netflix, Nucor, Xenon Pharmaceuticals Among Key Decliners
- Biohaven Shares Drop Following RBC Downgrade
- Xenon Pharmaceuticals Inc. - 8-K Filing
- JPMorgan Increases Price Target for Xenon Pharmaceuticals
- Octagon Capital Advisors Acquires $22.58 Million Stake in Xenon Pharmaceuticals Ahead of FDA Filing
- Xenon (XENE) Q1 2026 Earnings Call Summary
- Xenon Pharmaceuticals Inc. - 10-Q Filing
- Xenon Pharmaceuticals Inc. - 8-K Filing
- X-energy stock rises 27% on first day of trading following upsized IPO
- Climate Tech IPOs Begin to Gain Momentum with X-energy and Fervo
- X-energy Shares Rise 27% Following IPO Amid AI-Driven Interest in Nuclear Industry
- X-energy's Stock Rises 27% on Nasdaq Debut Following Upsized IPO
- X-energy, Backed by Amazon, Files for Up to $800M IPO
- Amazon-backed X-energy Files for Up to $800M IPO